MedTrace Logo

Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers

NCT02332044 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2015-01-06

No results posted yet for this study

Summary

The purpose of this study is to evaluate the drug-drug interaction between Erdosteine and Bepotastine besilate in healthy adult volunteers.

Conditions

  • Healthy

Interventions

DRUG

Erdos

capsule, 300mg

DRUG

Talion

tablet, 10mg

DRUG

Erdos, Talion

capsule 300mg and tablet 10mg

Sponsors & Collaborators

  • Daewoong Pharmaceutical Co. LTD.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2014-09-30
Completion
2015-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02332044 on ClinicalTrials.gov